Given these are voluntarily submitted from an undefined population, reliably gauging their occurrence or determining a direct link to the medication remains challenging, the FDA stated in the warning update
FDA-approved injectable brands include Ozempic (semaglutide, approved for type 2 diabetes), Wegovy (semaglutide, approved for chronic weight management), and Zepbound (tirzepatide, approved for chronic weight management)
Antioxidants 12 , 967 (2023)
Dysesthesia The TRIUMPH-4 trial data revealed a notable safety signal: dysesthesia (abnormal sensations like tingling, burning, or numbness) was reported in 8.8% of participants on the 9 mg dose and 20.9% on the 12 mg dose of retatrutide
The instability of this compound due to its high polyunsaturated fatty acid content presents formulation challenges, requiring advanced stabilization approaches including microencapsulation, nanoemulsification, and antioxidant co-formulations to enhance shelf-life and in vivo stability [6]
Clinical experience with crizotinib in patients with advanced ALK-rearranged non-small-cell lung cancer and brain metastases
